A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue. (Q39743982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

title

A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

Anna Orlova

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Irina Velikyan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

Mattias Sandström

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

publication date

4 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1356-1367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

68Ga-labelled DOTA-derivatised peptide ligands

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00259-009-1367-7

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

21 January 2018

1 reference

12 December 2020

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

1 reference

12 December 2020

Reducing renal uptake of radiolabeled peptides using albumin fragments

1 reference

12 December 2020

[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography

1 reference

12 December 2020

Her-2/neu expression in prostate cancer: a dynamic process?

1 reference

12 December 2020

68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression

1 reference

12 December 2020

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

1 reference

12 December 2020

Radiolabelling DOTA-peptides with 68Ga

1 reference

12 December 2020

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.

1 reference

12 December 2020

EGF-ERBB signalling: towards the systems level

1 reference

12 December 2020

Evaluation of the radiocobalt-labeled [MMA-DOTA-Cys61]-Z HER2:2395(-Cys) affibody molecule for targeting of HER2-expressing tumors

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules

1 reference

12 December 2020

68Ga-PET radiopharmacy: A generator-based alternative to 18F-radiopharmacy

1 reference

12 December 2020

Engineered two-helix small proteins for molecular recognition

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

1 reference

12 December 2020

Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy

1 reference

12 December 2020

A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression

1 reference

12 December 2020

Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease

1 reference

12 December 2020

Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: a metaanalysis

1 reference

12 December 2020

Imaging of HER-2 overexpression in tumors for guiding therapy

1 reference

12 December 2020

Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody

1 reference

12 December 2020

Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer

1 reference

12 December 2020

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

1 reference

12 December 2020

Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

1 reference

12 December 2020

Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity

1 reference

12 December 2020

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

1 reference

12 December 2020

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

12 December 2020

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin

1 reference

12 December 2020

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

1 reference

12 December 2020

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

12 December 2020

Fast and faster: a designed variant of the B-domain of protein A folds in 3 microsec

1 reference

12 December 2020

Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold

1 reference

12 December 2020

HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study

1 reference

12 December 2020

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases

1 reference

12 December 2020

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

12 December 2020

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.

1 reference

12 December 2020

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours

1 reference

12 December 2020

Update: affibody molecules for molecular imaging and therapy for cancer.

1 reference

12 December 2020

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

1 reference

12 December 2020

10.1007/S00259-009-1367-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20130858 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference